Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,581
Total Claims
$825K
Drug Cost
849
Beneficiaries
$972
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+16%
Opioid rate vs peers
2.6% vs 2.2% avg
-31%
Cost per patient vs peers
$972 vs $1,411 avg
-1%
Brand preference vs peers
10.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.6%
Opioid Rate
327
Opioid Claims
$3,908
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,317 claims · $646K
Generic: 11,169 claims · $175K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 81 | $65K |
| Empagliflozin | 64 | $58K |
| Tirzepatide | 44 | $53K |
| Dulaglutide | 38 | $46K |
| Dapagliflozin Propanediol | 51 | $40K |
| Insulin Degludec | 46 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $25K |
| Mirabegron | 32 | $24K |
| Evolocumab | 26 | $22K |
| Insulin Degludec | 32 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $19K |
| Semaglutide | 19 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $18K |
| Insulin Aspart | 11 | $16K |
| Linaclotide | 15 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
59%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About